ImmunArray
Diagnostic tests for autoimmune diseases based on microarray technology
ImmunArray has raised €9.1M across 1 funding round from 1 investor, most recently a Series B round in Jul 2016. Based in Rehovot, Israel; founded 2006; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€9.1M
€9,100,000
Funding rounds
1
Investors
1
distinct backers
Active since
2016-07
latest 2016-07
Funding by year
EUR raised per yearImmunArray — funding by year — interactive chart.
Data table
| ImmunArray — funding by year | |
|---|---|
| 2016 | €9.1M |
Signals
High confidenceRaise-next likelihood9
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2016-07-01 | Series B | €9.1M | Exigent Capital | View deal → |
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Trax€789MIsrael · Software
Global coverage: FundingData